Skip to content

MACUSAN: what changed

BE 1016.106.771NACE 86.220, Specialist medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€163,482
2024 · €29,768+€133,714
Equity
€192,584
2024 · €29,935+€162,649
Cash
€168,863
2024 · €2,603+€166,260
Balance sheet total
€224,067
2024 · €50,119+€173,948

Largest movements

2024 to 2025
Assets
  • Cash +€166,260

    up €166,260 (+6,386%), from €2,603 to €168,863

    mainly Net result for the year (+€163,482) and Tax, wage and social debts (+€22,993)

  • Deferred charges and accrued income +€6,674

    new in 2025: €6,674

Equity and liabilities
  • Profit (loss) carried forward +€162,649

    up €162,649 (+562%), from €28,935 to €191,584

  • Tax, wage and social debts +€22,993

    up €22,993 (+294%), from €7,828 to €30,821

  • Other debts -€11,586

    down €11,586 (-95.2%), from €12,169 to €583

Income statement
  • Gross operating margin +€177,101

    up €177,101 (+474%), from €37,350 to €214,451

  • Taxes +€42,993

    up €42,993 (+567%), from €7,578 to €50,571

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €29,768
Gross operating margin +€177,101
Depreciation -€315
Other operating charges -€149
Financial income +€112
Financial charges -€42
Taxes -€42,993
Result 2025 €163,482
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€168,217
Investment -€1,124
Financing -€833
Cash 2024 €2,603
Net result for the year +€163,482
Depreciation +€315
Smaller working-capital items -€313
Deferred charges and accrued income -€6,674
Tax, wage and social debts +€22,993
Other debts -€11,586
Investment in fixed assets (net) -€1,124
Contributions, distributions and other -€833
Cash 2025 €168,863
brings cash intakes cash out
Every line side by side 33 lines
Line Code 2024 2025 Change %
Total assets 20/58 €50,119 €224,067 +€173,948 +347%
Fixed assets 21/28 - €809 +€809
Tangible fixed assets 22/27 - €809 +€809
Furniture and vehicles 24 - €809 +€809
Current assets 29/58 €50,119 €223,259 +€173,140 +345%
Amounts receivable within one year 40/41 €47,516 €47,721 +€206 +0.4%
Trade receivables 40 €47,516 €43,584 -€3,932 -8.3%
Other amounts receivable 41 - €4,137 +€4,137
Cash at bank and in hand 54/58 €2,603 €168,863 +€166,260 +6,386%
Deferred charges and accrued income 490/1 - €6,674 +€6,674
Total equity and liabilities 10/49 €50,119 €224,067 +€173,948 +347%
Equity 10/15 €29,935 €192,584 +€162,649 +543%
Contributions 10/11 €1,000 €1,000 = 0.0%
Profit (loss) carried forward 14 €28,935 €191,584 +€162,649 +562%
Amounts payable 17/49 €20,184 €31,484 +€11,300 +56.0%
Amounts payable within one year 42/48 €20,184 €31,484 +€11,300 +56.0%
Trade debts 44 €187 €79 -€108 -57.5%
Suppliers 440/4 €187 €79 -€108 -57.5%
Taxes, remuneration and social security 45 €7,828 €30,821 +€22,993 +294%
Taxes 450/3 €7,828 €30,821 +€22,993 +294%
Other amounts payable 47/48 €12,169 €583 -€11,586 -95.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 - €315 +€315
Other operating charges 640/8 - €149 +€149
Gross operating margin 9900 €37,350 €214,451 +€177,101 +474%
Operating profit (loss) 9901 €37,350 €213,987 +€176,637 +473%
Financial income 75/76B - €112 +€112
Recurring financial income 75 - €112 +€112
Financial charges 65/66B €4 €46 +€42 +1,131%
Recurring financial charges 65 €4 €46 +€42 +1,131%
Profit (loss) for the period before taxes 9903 €37,346 €214,053 +€176,707 +473%
Income taxes 67/77 €7,578 €50,571 +€42,993 +567%
Profit (loss) for the period 9904 €29,768 €163,482 +€133,714 +449%
Profit (loss) for the period to be appropriated 9905 €29,768 €163,482 +€133,714 +449%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€441,381 to €579,417

Midpoint €498,896 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €192,584
Capitalised earnings €690,179 to €966,250
Indication €441,381 to €579,417

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€192,584
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€192,584

Capitalised earnings

net result for the year (9904)
2025
€163,482
2024
€29,768
Average result
€96,625
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€690,179 / €805,208 / €966,250

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 11 November 2026 via checked.be.